Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study-Reference-Cited by-同舟云学术

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study

Published:2016-03-22 Issue:10 Volume:18 Page:1442-1450
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:NEUONC

Author:

Jakacki Regina I.,Cohen Kenneth J.,Buxton Allen,Krailo Mark D.,Burger Peter C.,Rosenblum Marc K.,Brat Daniel J.,Hamilton Ronald L.,Eckel Sandrah P.,Zhou Tianni,Lavey Robert S.,Pollack Ian F.

Funder

National Institutes of Health

Children's Oncology Group

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/10/1442/17430589/now038.pdf

Reference25 articles.

1. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group

2. O6-Methylguanine-DNA Methyltransferase Expression Strongly Correlates With Outcome in Childhood Malignant Gliomas: Results From the CCG-945 Cohort